On August 25, 2026, Much Wow Ltd., a UK-based entity focused on the Dogecoin ecosystem, filed a Schedule 13D disclosing a new 10.1% stake in House of Doge Inc. (TBH). The reporting person acquired 7,718,866 shares of Common Stock as merger consideration following a transaction completed on June 30, 2026. No cash consid...

Walter V. Klemp, Chairman, CEO, and President of Moleculin Biotech, Inc. (MBRX), filed a Schedule 13D reporting a significant increase in beneficial ownership. On August 3, 2026, Mr. Klemp acquired 533,333 shares of Common Stock and Series I Common Stock Purchase Warrants to purchase up to 1,599,999 additional shares t...

Walter V. Klemp, Chairman, CEO, and President of Moleculin Biotech, Inc. (MBRX), filed a Schedule 13D reporting a significant increase in beneficial ownership. On August 3, 2026, Mr. Klemp acquired 533,333 shares of Common Stock and Series I Common Stock Purchase Warrants to purchase up to 1,599,999 additional shares t...

Jonathan P. Foster, the Executive Vice President and Chief Financial Officer of Moleculin Biotech, Inc. (MBRX), filed a Schedule 13D on August 25, 2026, reporting a new 6.3% beneficial ownership stake in the company. The position consists of 1,288,207 shares of common stock, which includes 305,673 shares held directly,...

On August 25, 2026, Much Wow Ltd., a UK-based entity focused on the Dogecoin ecosystem, filed a Schedule 13D disclosing a new 10.1% stake in House of Doge Inc. (TBH). The reporting person acquired 7,718,866 shares of Common Stock as merger consideration following a transaction completed on June 30, 2026. No cash consid...

Fred Tejada, newly appointed Director and Senior VP of Nu-Med Plus, Inc. (NUMD), filed this Schedule 13D to report the acquisition of beneficial ownership of 8,131,250 shares of Common Stock, representing approximately 9.7% of the class. This position was established on July 8, 2026, primarily through a Voting Agreemen...

Fred Tejada, newly appointed Director and Senior VP of Nu-Med Plus, Inc. (NUMD), filed this Schedule 13D to report the acquisition of beneficial ownership of 8,131,250 shares of Common Stock, representing approximately 9.7% of the class. This position was established on July 8, 2026, primarily through a Voting Agreemen...

On August 25, 2026, Fund 1 Investments, LLC filed a Schedule 13D reporting a 9.9% stake in Xponential Fitness, Inc. (XPOF), consisting of 4,170,610 shares of Class A common stock. The reporting person, managed by Jonathan Lennon, acquired these shares for approximately $25.85 million using working capital. The filing i...

On August 24, 2026, private investor Jorey Chernett filed a Schedule 13D disclosing a 5.5% stake in CVRx, Inc. (CVRX), consisting of 1,461,750 shares. This filing represents a transition from a previous Schedule 13G filing to an active 13D status. Chernett, who acquired the shares for approximately $8 million using per...

On August 24, 2026, private investor Jorey Chernett filed a Schedule 13D disclosing a 5.5% stake in CVRx, Inc. (CVRX), consisting of 1,461,750 shares. This filing represents a transition from a previous Schedule 13G filing to an active 13D status. Chernett, who acquired the shares for approximately $8 million using per...

On August 21, 2026, LNA Holding SRL (LNH) acquired 10,953,543 shares of Martin Marietta Materials, Inc. (MLM) common stock, representing a 15.4% ownership stake. The shares were issued as partial consideration for Martin Marietta's acquisition of Lhoist North America, Inc. from LNH, which also included $7 billion in ca...

On August 21, 2026, LNA Holding SRL (LNH) acquired 10,953,543 shares of Martin Marietta Materials, Inc. (MLM) common stock, representing a 15.4% ownership stake. The shares were issued as partial consideration for Martin Marietta's acquisition of Lhoist North America, Inc. from LNH, which also included $7 billion in ca...

On August 24, 2026, Brian Valania, the Chief Executive Officer, Chief Financial Officer, and a director of Mitesco, Inc. (MITI), filed a Schedule 13D reporting a significant increase in beneficial ownership. Following a series of board-approved compensation grants, Valania now beneficially owns 3,421,078 shares of Comm...

Suzano Holding S.A., along with several individual members of the Feffer and Guper families (the "Reporting Persons"), filed a Schedule 13D on August 24, 2026, regarding their ownership in Suzano S.A. The filing reports a collective beneficial ownership of 607,747,376 shares, representing approximately 48.1% of the com...

Suzano Holding S.A., along with several individual members of the Feffer and Guper families (the "Reporting Persons"), filed a Schedule 13D on August 24, 2026, regarding their ownership in Suzano S.A. The filing reports a collective beneficial ownership of 607,747,376 shares, representing approximately 48.1% of the com...

On August 24, 2026, Brian Valania, the Chief Executive Officer, Chief Financial Officer, and a director of Mitesco, Inc. (MITI), filed a Schedule 13D reporting a significant increase in beneficial ownership. Following a series of board-approved compensation grants, Valania now beneficially owns 3,421,078 shares of Comm...

Dr. Shao-Lee Lin, the President and CEO of Cue Biopharma, Inc. (CUE), filed a Schedule 13D reporting a 6.2% beneficial ownership stake in the company. This initial 13D filing follows Dr. Lin's appointment as CEO on May 3, 2026. The reported 467,166 shares include 378,458 shares held directly, 20,471 shares from RSUs ve...

Eric Singer, the President, Chief Executive Officer, and Chairman of Immersion Corp (IMMR), filed a Schedule 13D reporting a 5.5% stake in the company. As of August 21, 2026, Mr. Singer beneficially owns 1,826,961 shares of common stock. This position includes 397,825 shares purchased with personal funds in the open ma...

On July 21, 2026, Erqi Wang, the CEO and Chairman of Jin Medical International Ltd. (ZJYL), engaged in a series of recapitalization transactions to preserve voting control. The issuer repurchased 3,769,057 Class A Ordinary Shares from Jolly Harmony Enterprises Limited (wholly owned by Wang) and subsequently issued an e...

Dr. Shao-Lee Lin, the President and CEO of Cue Biopharma, Inc. (CUE), filed a Schedule 13D reporting a 6.2% beneficial ownership stake in the company. This initial 13D filing follows Dr. Lin's appointment as CEO on May 3, 2026. The reported 467,166 shares include 378,458 shares held directly, 20,471 shares from RSUs ve...

Eric Singer, the President, Chief Executive Officer, and Chairman of Immersion Corp (IMMR), filed a Schedule 13D reporting a 5.5% stake in the company. As of August 21, 2026, Mr. Singer beneficially owns 1,826,961 shares of common stock. This position includes 397,825 shares purchased with personal funds in the open ma...

On July 21, 2026, Erqi Wang, the CEO and Chairman of Jin Medical International Ltd. (ZJYL), engaged in a series of recapitalization transactions to preserve voting control. The issuer repurchased 3,769,057 Class A Ordinary Shares from Jolly Harmony Enterprises Limited (wholly owned by Wang) and subsequently issued an e...

On August 20, 2026, Hong Zhiwang filed a Schedule 13D reporting a significant increase in his holdings of Addentax Group Corp. (ATXG). As of the event date on August 19, 2026, Hong Zhiwang beneficially owns 225,174 shares of common stock, representing approximately 10.7% of the company's outstanding shares. This positi...

Sireesh Appajosyula, the Director and Chief Operating Officer of Hepion Pharmaceuticals, Inc. (HEPA), filed a Schedule 13D on August 20, 2026, reporting a new 5.7% ownership stake in the company. The reporting person beneficially owns a total of 5,250,000 shares of common stock. This position was built through two prim...

On August 20, 2026, Conifer Management, L.L.C., led by Managing Member Gregory Alexander, filed a Schedule 13D indicating an increased ownership stake in Group 1 Automotive, Inc. (GPI). The reporting person now beneficially owns 1,157,100 shares of common stock, representing approximately 9.7% of the class, up from a p...